Gene Expression and Pharmacodynamic Changes in 1,760 Systemic Lupus Erythematosus Patients From Two Phase III Trials of BAFF Blockade With Tabalumab.

about

Hepatic expression profiles in retroviral infection: relevance to drug hypersensitivity risk.Lupus community panel proposals for optimising clinical trials: 2018.

P2860

Q33777950-C3600957-5C9B-4874-B170-D514C24004AD Q52320880-6F99F062-0D56-423B-BDAF-221838BDD69F

P2860

Gene Expression and Pharmacodynamic Changes in 1,760 Systemic Lupus Erythematosus Patients From Two Phase III Trials of BAFF Blockade With Tabalumab.

Item

http://www.wikidata.org/entity/Q38813080

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Gene Expression and Pharmacody ...... BAFF Blockade With Tabalumab.

@en

type

Item

label

Gene Expression and Pharmacody ...... BAFF Blockade With Tabalumab.

@en

prefLabel

Gene Expression and Pharmacody ...... BAFF Blockade With Tabalumab.

@en

P1476

Gene Expression and Pharmacody ...... BAFF Blockade With Tabalumab.

@en

P2093

David C Airey

http://www.w3.org/2001/XMLSchema#string

Eric Nantz

http://www.w3.org/2001/XMLSchema#string

Ernst R Dow

http://www.w3.org/2001/XMLSchema#string

Guilherme V Rocha

http://www.w3.org/2001/XMLSchema#string

Joan T Merrill

http://www.w3.org/2001/XMLSchema#string

Krista M Schroeder

http://www.w3.org/2001/XMLSchema#string

Laura K Nisenbaum

http://www.w3.org/2001/XMLSchema#string

Matthew D Linnik

http://www.w3.org/2001/XMLSchema#string

Narayanan B Perumal

http://www.w3.org/2001/XMLSchema#string

Richard E Higgs

http://www.w3.org/2001/XMLSchema#string

P2860

WGCNA: an R package for weighted correlation network analysis

BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth

Human housekeeping genes, revisited

Summaries of Affymetrix GeneChip probe level data

Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus

IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis

Network analysis of associations between serum interferon-α activity, autoantibodies, and clinical features in systemic lupus erythematosus

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

P304

643-654

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ART.39950

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Marta E Alarcón-Riquelme

Michelle A. Petri

P577

2017-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27723281

http://www.w3.org/2001/XMLSchema#string

P921

phase III clinical trial

P932

6585752

http://www.w3.org/2001/XMLSchema#string

Gene Expression and Pharmacodynamic Changes in 1,760 Systemic Lupus Erythematosus Patients From Two Phase III Trials of BAFF Blockade With Tabalumab.

about

P2860

P2860

Gene Expression and Pharmacodynamic Changes in 1,760 Systemic Lupus Erythematosus Patients From Two Phase III Trials of BAFF Blockade With Tabalumab.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932